Chih-An Lin

966 total citations
9 papers, 399 citations indexed

About

Chih-An Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chih-An Lin has authored 9 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Chih-An Lin's work include Lung Cancer Treatments and Mutations (4 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Chih-An Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Chih-An Lin collaborates with scholars based in Taiwan, United States and Italy. Chih-An Lin's co-authors include Chao‐Chi Ho, Chong‐Jen Yu, Jin‐Yuan Shih, Wei‐Yu Liao, James Chih‐Hsin Yang, Melissa M. Keenan, Jianli Wu, Xiaohu Tang, Jen‐Tsan Chi and Susan K. Murphy and has published in prestigious journals such as Cancer Research, PLoS Genetics and Cancer Letters.

In The Last Decade

Chih-An Lin

8 papers receiving 396 citations

Peers

Countries citing papers authored by Chih-An Lin

Since Specialization

Citations

This map shows the geographic impact of Chih-An Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih-An Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih-An Lin more than expected).

Fields of papers citing papers by Chih-An Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih-An Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih-An Lin. The network helps show where Chih-An Lin may publish in the future.

Co-authorship network of co-authors of Chih-An Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chih-An Lin. A scholar is included among the top collaborators of Chih-An Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih-An Lin. Chih-An Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patients 2024 ·Clinical Epigenetics ·Yi‐Jing Hsiao, (unknown), (unknown), Nai‐Hsin Chi, Hsi‐Yu Yu, Tsai-Hsia Hong, Hsuan‐Yu Chen, (unknown), Shuenn‐Wen Kuo, Kang‐Yi Su, Wen‐Je Ko, Li‐Ming Hsu, Chih-An Lin, (unknown), (unknown), Yih‐Sharng Chen, Sung‐Liang Yu	0
2	The Optimal Primary Treatment for Pediatric Perianal Abscess and Anal Fistula: A Systemic Review and Meta-Analysis 2023 ·Journal of Pediatric Surgery ·Chih-An Lin, Chia‐Man Chou, (unknown), (unknown)	4
3	Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors 2023 ·BMC Cancer ·Chun‐Ta Huang, Chih-An Lin, Te‐Jen Su, Ching‐Yao Yang, Tzu-Hsiu Tsai, Chia‐Lin Hsu, Wei‐Yu Liao, Kuan‐Yu Chen, Chao‐Chi Ho, Chong‐Jen Yu	7
4	Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer 2021 ·Cancer Letters ·Chia‐Yi Lin, Kuo‐Yen Huang, Yi‐Chun Lin, Shuenn‐Chen Yang, (unknown), Yih‐Leong Chang, Jin‐Yuan Shih, Chao‐Chi Ho, Chih-An Lin, (unknown), Ya‐Hsuan Chang, Shih-Han Kao, Pan‐Chyr Yang	20
5	EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs 2018 ·Journal of Thoracic Oncology ·Chih-An Lin, Sung‐Liang Yu, Hsuan‐Yu Chen, Huei‐Wen Chen, (unknown), Chia‐Ching Chang, Chong‐Jen Yu, Pan‐Chyr Yang, Chao‐Chi Ho	15
6	Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas 2016 ·Cancer Research ·Xiaohu Tang, Jianli Wu, Chien‐Kuang Cornelia Ding, Min Lu, Melissa M. Keenan, Chao‐Chieh Lin, Chih-An Lin, (unknown), Daniel J. George, David S. Hsu, Jen‐Tsan Chi	67
7	Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib 2016 ·Journal of Thoracic Oncology ·Chao‐Chi Ho, Wei‐Yu Liao, Chih-An Lin, Jin‐Yuan Shih, Chong‐Jen Yu, James Chih‐Hsin Yang	175
8	Hedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinoma 2016 ·Oncotarget ·(unknown), Yu-Rung Kao, Chih-An Lin, Paula Kuo, Shengping Yang, (unknown), Teh‐Ying Chou, Chao‐Chi Ho, Cheng‐Wen Wu	37
9	Comprehensive Profiling of Amino Acid Response Uncovers Unique Methionine-Deprived Response Dependent on Intact Creatine Biosynthesis 2015 ·PLoS Genetics ·Xiaohu Tang, Melissa M. Keenan, Jianli Wu, Chih-An Lin, Laura G. Dubois, J. Will Thompson, Stephen J. Freedland, Susan K. Murphy, Jen‐Tsan Chi	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact